These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5275614)

  • 1. [The effect of various antitumor drugs on developing Schwez erythromyelosis in rats].
    Emanuel' NM; Dronova LM; Erokhin VN; Belich EI
    Izv Akad Nauk SSSR Biol; 1970; 1():87-92. PubMed ID: 5275614
    [No Abstract]   [Full Text] [Related]  

  • 2. [Status of plasma blood clotting factors during different stages of erythromyelosis in rats and the effect of hexaphosphamide on the indices studied].
    Stepanian MA; Chilingarian AG; Muradian LB
    Zh Eksp Klin Med; 1978; 18(2):24-8. PubMed ID: 278414
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stable drug resistance to paraphenacyl in a strain of rats with transplanted leukemia (erythromyelosis)].
    Khomchenovskiĭ EI
    Biull Eksp Biol Med; 1968; 65(6):71-4. PubMed ID: 5273159
    [No Abstract]   [Full Text] [Related]  

  • 4. [A comparative quantitative study of the anti-leukemia activity of hexaphosphamide, various anti-leukemia preparations and x-rays].
    Khomchenovskiĭ EI
    Biull Eksp Biol Med; 1968 Apr; 65(4):90-3. PubMed ID: 4991414
    [No Abstract]   [Full Text] [Related]  

  • 5. [Characteristics of antineoplastic activity of some chemical compounds on the kinetic model of erythromyelosis in rats].
    Emanuél' NM; Dronova NM; Erokhin VN; Belich EI
    Izv Akad Nauk SSSR Biol; 1968; 2():181-91. PubMed ID: 5261112
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of the studies of ethyleneiminotriazines].
    Ivin BA; Kraĭz BO; Korsakov MV; Stukov AN; Sheĭman VP; Filov VA
    Vopr Onkol; 1990; 36(1):6-12. PubMed ID: 2407028
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of experimental and clinical studies of a new antileukemic drug: hexaphosphamide. Review of the literature and the author's own results].
    Khomchenovskii EI
    Haematologia (Budap); 1977; 11(1-2):115-26. PubMed ID: 352850
    [No Abstract]   [Full Text] [Related]  

  • 8. Walker carcinosarcoma 256 in study of anticancer agents. II. Results.
    Everett J
    Cancer Res; 1966 Aug; 26(8 Pt 2):942-9. PubMed ID: 4224206
    [No Abstract]   [Full Text] [Related]  

  • 9. The antineoplastic activity of hexaziridinocyclotriphosphazene (Myko 63) in murine tumors.
    Malfiore C; Marmonti L; Filippeschi S; Labarre JF; Spreafico F
    Anticancer Res; 1983; 3(6):425-9. PubMed ID: 6230986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paramagnetic diethyleneimides of urethane phosphoric acids as antitumor agents].
    Emanuél' NM; Zhdanov RI; Konovalova NP; Vasil'eva LS; Buina NA
    Vopr Onkol; 1980; 26(5):54-8. PubMed ID: 6247836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological properties and antitumor activity of a preparation diiodo-benzo-tepa in experiments].
    Trinus FP; Sologub PY; Protsenko LD; Tarnavskaya MI; Nikolaeva SV; Danilenko VS; Sharykina NI; Kolodyazhny VI; Zaikina RG; Goncharenko GV; Kopel'nik MA; Andrianova SM
    Vopr Onkol; 1979; 25(9):53-8. PubMed ID: 90429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mouse leukemia induced by cell-free filtrates from transplantable erythromyelosis of rats].
    Verkhats'kiĭ PP; Gluzman DF
    Mikrobiol Zh; 1972; 34(1):58. PubMed ID: 4507245
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tactics of cytostatic therapy of primary and secondary (post-erythremic) myelofibrosis].
    Demidova AV; Sysoeva NA
    Probl Gematol Pereliv Krovi; 1976 Jul; 21(7):23-7. PubMed ID: 1071792
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of zymosan on the toxicity and activity of various antitumor preparations].
    Veksler IG
    Vopr Onkol; 1966; 12(8):80-6. PubMed ID: 4972211
    [No Abstract]   [Full Text] [Related]  

  • 15. [The functional activity of the natural killers during the experimental treatment of hemoblastoses].
    Gashchuk AP; Evtukh VP; Zverkova AS
    Vrach Delo; 1990 Nov; (11):64-6. PubMed ID: 2098989
    [No Abstract]   [Full Text] [Related]  

  • 16. [The theoretical bases of chemotherapy of hemoblastosis].
    Baserga A
    Minerva Med; 1966 Mar; 57(25):1082-6. PubMed ID: 5219053
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possible mechanism of the selectivity of the cytostatic effect of antitumor preparations].
    Konradov AA; Levitin EI; Maksimov VM
    Izv Akad Nauk SSSR Biol; 1979; (3):378-82. PubMed ID: 458027
    [No Abstract]   [Full Text] [Related]  

  • 18. [Leukemia P 1534 as an experimental model for the study of antineoplastic drugs].
    Radzikowski C
    Postepy Hig Med Dosw; 1965; 19(5):647-82. PubMed ID: 5324386
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-leukemic activity of 15-deoxyspergualin against N-butyl-N-nitrosourea-induced autochthonous rat leukemia.
    Ito J; Yamashita T; Takahashi K; Horinishi H; Nakamura T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Oct; 39(10):1488-90. PubMed ID: 3465716
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies and progress on the enhancement of therapeutic effects of antitumor drugs].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1107-15. PubMed ID: 6408997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.